tumor clonality in egfr mutation-positive nsclc
Published 5 years ago • 6K plays • Length 10:30Download video MP4
Download video MP3
Similar videos
-
4:56
optimizing outcomes in egfr mutation-positive nsclc with tkis
-
6:28
sequential treatment with afatinib and osimertinib in patients with egfr mutation-positive nsclc
-
6:43
sequential afatinib and osimertinib in egfr mutation-positive nsclc patients: updated results
-
1:25
current treatment recommendations and future directions for egfr-mutant nsclc
-
45:43
egfr mutant lung cancer: 2013 update
-
5:02
egfr-mutant lung cancer: initial approach
-
1:41
egfr mutations in patients with lung cancer
-
7:08
emerging data in egfr-mutant lung cancer
-
18:51
gracecast-140_lung_highlights in lung cancer, 2012: new options for egfr mutation-positive nsclc
-
1:04
molecular testing in egfr mutant driven nsclc
-
5:55
a case of egfr-mutant non–small cell lung cancer
-
1:26
first line treatment of egfr mutation-positive nsclc
-
2:26
egfr mutations in nsclc
-
17:45
individual treatments for individual egfr mutations
-
0:48
current role of immunotherapy in egfr-mutant lung cancer
-
13:26
debate: drug of choice for exon 19 del egfr mutant nsclc - any egfr tki
-
10:39
gracecast - lcvl - can patients with an egfr mutation-positive advanced nsclc benefit from immunothe
-
4:51
understanding egfr-mutant nsclc subsets
-
13:06
managing t790-negative egfr-mutated nsclc